<p>Sentinel node biopsy (SNB) plays a key role in assessing the prognosis of melanomas.</p>
<p>In this fireside chat from our new SNB Training Program (<a href="https://melanomaeducation.org.au/courses/melanoma201/" target="_blank" rel="noopener noreferer">Sentinel Node Biopsy: From guidelines to practice</a>), MIA’s Prof Georgina Long AO, Prof John Thompson AO and A/Prof Sydney Ch’ng discuss:</p>
<ul>
 <li>the history of SNB in the management of melanoma</li>
 <li>its current role in the stratification of patients into those who may benefit from adjuvant therapies verses those for whom active surveillance is more appropriate</li>
 <li>other potential benefits of SNB, including the likelihood of SNB itself reducing the risk of nodal recurrence.</li>
</ul>
<p>This podcast is suitable for Surgeons, Medical Oncologists, General Practitioners and other healthcare professionals.</p>
<p><br></p>
<p>SPEAKERS</p>
<ul>
 <li>A/Prof Sydney Ch’ng - Plastic &amp; Reconstructive Surgeon and Head &amp; Neck Surgeon, Melanoma Institute Australia | Associate Professor of Surgery, The University of Sydney</li>
  <li>Prof Georgina Long AO - Co-Medical Director, Melanoma Institute Australia | Chair, Melanoma Medical Oncology and Translational Research, Melanoma Institute Australia and Royal North Shore Hospital, The University of Sydney</li>
  <li>Prof John Thompson AO - Emeritus Professor of Melanoma and Surgical Oncology, The University of Sydney | Senior Surgeon, Melanoma Institute Australia</li>
</ul>
<p><br></p>
<p>Please note that this podcast was accurate at the time of recording (July 2022) but may not reflect the rapidly evolving treatment landscape and approvals in Australia.</p>

Melanoma Insights for Professionals

Melanoma Institute Australia

When to recommend a sentinel node biopsy in melanoma

JUL 7, 202333 MIN
Melanoma Insights for Professionals

When to recommend a sentinel node biopsy in melanoma

JUL 7, 202333 MIN

Description

<p>Sentinel node biopsy (SNB) plays a key role in assessing the prognosis of melanomas.</p> <p>In this fireside chat from our new SNB Training Program (<a href="https://melanomaeducation.org.au/courses/melanoma201/" target="_blank" rel="noopener noreferer">Sentinel Node Biopsy: From guidelines to practice</a>), MIA’s Prof Georgina Long AO, Prof John Thompson AO and A/Prof Sydney Ch’ng discuss:</p> <ul> <li>the history of SNB in the management of melanoma</li> <li>its current role in the stratification of patients into those who may benefit from adjuvant therapies verses those for whom active surveillance is more appropriate</li> <li>other potential benefits of SNB, including the likelihood of SNB itself reducing the risk of nodal recurrence.</li> </ul> <p>This podcast is suitable for Surgeons, Medical Oncologists, General Practitioners and other healthcare professionals.</p> <p><br></p> <p>SPEAKERS</p> <ul> <li>A/Prof Sydney Ch’ng - Plastic &amp; Reconstructive Surgeon and Head &amp; Neck Surgeon, Melanoma Institute Australia | Associate Professor of Surgery, The University of Sydney</li> <li>Prof Georgina Long AO - Co-Medical Director, Melanoma Institute Australia | Chair, Melanoma Medical Oncology and Translational Research, Melanoma Institute Australia and Royal North Shore Hospital, The University of Sydney</li> <li>Prof John Thompson AO - Emeritus Professor of Melanoma and Surgical Oncology, The University of Sydney | Senior Surgeon, Melanoma Institute Australia</li> </ul> <p><br></p> <p>Please note that this podcast was accurate at the time of recording (July 2022) but may not reflect the rapidly evolving treatment landscape and approvals in Australia.</p>